Description
This paradoxical finding contradicts the established dogma that higher tau burden correlates with worse cognitive function. The disconnect between pathological load and functional resilience challenges current therapeutic approaches targeting tau reduction and suggests alternative neuroprotective mechanisms.
Gap type: contradiction Source paper: DAP12 deletion reduces neuronal SLIT2 and demyelination and enhances brain resilience in female tauopathy mice. (2025, Molecular neurodegeneration, PMID:41331787)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:46.324982+00:00”, “resolution_summary”: “Resolved by hypothesis h-aa1f5de5cd: TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switching from protective ‘disease-associated microglia’ to neurotoxic 'inflammasome-act. Supporting evidence includes debate sess_SDA-2026-04-15-gap-pubmed-20260411-075356-20920528_20260416-034507.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-aa1f5de5cd”, “title”: “TREM2 haploinsufficiency dysregulates microglial synaptic surveillance, switching from protective ‘disease-associated microglia’ to neurotoxic ‘inflammasome-active’ states”, “score”: 0.235, “reason”: “20 token overlaps; entity overlap: dap12”, “analysis_id”: “SDA-2026-04-02-gap-synaptic-pruning-microglia”, “target_gene”: “TREM2, TYROBP (DAP12), APOE”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.7, “confidence_score”: 0.22, “status”: “proposed”, “pubmed_evidence_ids”: [“26598730”, “27753624”, “28602351”, “28802038”, “29070674”]}, {“id”: “h-adfcd3f146”, “title”: “TREM2 Crosstalk and Synergistic Activation of Phagocytic Transcriptome”, “score”: 0.233, “reason”: “19 token overlaps; entity overlap: dap12”, “analysis_id”: “SDA-2026-04-06-gap-pubmed-20260406-062118-e3613755”, “target_gene”: “TREM2/DAP12 (TYROBP)”, “target_pathway”: null, “disease”: “neuroinflammation”, “composite_score”: 0.740427, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“27929062”, “29262351”, “30470797”, “33093479”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-075356-20920528_20260416-034507”, “title”: “This finding contradicts the established paradigm that autophagy is generally protective in neurons and neurodegenerative diseases. The counterintuitive result that blocking autophagy reduces neuronal death challenges current therapeutic approaches targeting autophagy enhancement.\n\nGap type: contradiction\nSource paper: Autophagy fails to prevent glucose deprivation/glucose reintroduction-induced neuronal death due to calpain-mediated lysosomal dysfunction in cortical neurons. (2017, Cell death & disease, PMID:28661473)”, “score”: 0.542, “reason”: “17 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-075356-20920528”, “quality_score”: 0.74, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-180532-e8930cb8”, “title”: “The abstract shows V1613M variant reduces amyloid plaques and damage in 5xFAD mice, yet ABCA7 loss-of-function mutations increase LOAD risk. This apparent contradiction suggests complex genotype-phenotype relationships that could inform therapeutic targeting.\n\nGap type: contradiction\nSource paper: The Abca7 (None, None, PMID:38506634)”, “score”: 0.474, “reason”: “13 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-180532-e8930cb8”, “quality_score”: 0.6, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-12-gap-pubmed-20260410-180503-a7a03974_20260412-213444”, “title”: “The abstract suggests that Aβ-tau synergy could explain negative results from anti-Aβ trials, contradicting the expectation that targeting the presumed initiating pathology would be therapeutic. This contradiction has major implications for therapeutic strategy design.\n\nGap type: contradiction\nSource paper: Synergy between amyloid-β and tau in Alzheimer’s disease. (2020, Nature neuroscience, PMID:32778792)”, “score”: 0.419, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-12-gap-pubmed-20260410-180503-a7a03974”, “quality_score”: 0.7, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-pubmed-20260410-180503-a7a03974_20260416-134419”, “title”: “The abstract suggests that Aβ-tau synergy could explain negative results from anti-Aβ trials, contradicting the expectation that targeting the presumed initiating pathology would be therapeutic. This contradiction has major implications for therapeutic strategy design.\n\nGap type: contradiction\nSource paper: Synergy between amyloid-β and tau in Alzheimer’s disease. (2020, Nature neuroscience, PMID:32778792)”, “score”: 0.419, “reason”: “11 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-180503-a7a03974”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-174607-708e8d91”, “title”: “The finding that Mertk/Axl deficiency increases viral susceptibility contradicts the established paradigm that TAM receptors dampen antiviral immunity. This unexpected protective role challenges current understanding of TAM receptor function in neuroinvasive infections.\n\nGap type: contradiction\nSource paper: The TAM receptor Mertk protects against neuroinvasive viral infection by maintaining blood-brain barrier integrity. (2015, Nature medicine, PMID:26523970)”, “score”: 0.414, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-174607-708e8d91”, “quality_score”: 0.75, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}